Week in Washington

Every week, Wakely Director, Michael Cohen, Ph.D., brings you the latest news on healthcare policy developments in Washington. From minor changes that could majorly affect your organization to sweeping policy shifts that impact the entire industry, Week in Washington gives you the news you need to know.

  • Week in Washington 07/18/24

    Post-Chevron

    As discussed last week, the post-Chevron legal landscape would invite a litigation around HHS regulations. Three cases that have already opened up are around hospital payments (A New Jersey-based hospital is suing HHS over payments calculations to disproportionate share hospitals), non-discrimination requirements (enforcement of protections for LGBTQ= patients), and title X (withholding of federal funds if states don’t provide abortion counseling). More cases are expected to be filled.

    ACA Rates

    More states have released proposed/preliminary 2025 ACA rates. You can follow the releases here. Indiana currently represents the only state to have an average premium decrease (-1.6%) and New York with the highest (16%). There appears to be higher than normal trend pressures that is pushing rates higher although this is still a very preliminary picture.

    Medicare Prescription Drug Payment Plan

    CMS released the final part two guidance around plan outreach and education for the Medicare Prescription Drug Payment Plan. Starting in 2025, the Medicare Prescription Drug Payment Plan, beneficiaries will have the option of spreading their prescription drug costs out over the calendar year. 

    Covid

    The CDC reported that Covid cases are increasing. Last week saw a 23.5% increase in emergency room visits. Florida in particular appears to have high levels of Covid related emergency room visits.

Previous Editions

Ready to connect with a Wakely expert?

Request a consultation